Latest / The 7investing Podcast
The Next Generation of Health Care with Kelly ETFs Founder Kevin Kelly
The disruptive potential of gene editing could have huge implications for health care. Suddenly, several chronic diseases -- which may have required patients to be treated for decades -- have a potential to be fundamentally cured at the genomic level.
This is unlocking publicly-tradable investment opportunities. Companies are utilizing the power of CRISPR gene editing, base editing, and prime editing to directly modify patient DNA. Larger pharmaceutical companies are partnering with these smaller drug developers and are building commercial programs that could be worth billions of dollars…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.